SR
Suraj Ramillawar
About Suraj Ramillawar
Data last updated:
Suraj Ramillawar has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Samsun Oxylyf Private Limited and Pharmapathy Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Pharmapathy Private Limited at ₹1.56 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Apr 2022 | 2022 | ₹1.56 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jul 2021 | 2021 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suraj Ramillawar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suraj Ramillawar
Suraj Ramillawar has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Samsun Oxylyf Private Limited and Pharmapathy Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Pharmapathy Private Limited at ₹1.56 Cr (FY 2024).
Suraj Ramillawar is associated with 1 company as Director, including Pharmapathy Private Limited (₹1.56 Cr).
Suraj Ramillawar has expertise in General Business.
Suraj Ramillawar has 5 years in corporate governance.
By reported revenue, the largest current company of Suraj Ramillawar is Pharmapathy Private Limited, with revenue of ₹1.56 Cr (FY 2024).
Suraj Ramillawar currently holds positions at 1 company: Pharmapathy Private Limited (₹1.56 Cr).